Myalept Interactions
There are 203 drugs known to interact with Myalept (metreleptin), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 3 are major, 191 are moderate, and 9 are minor.
- View all 203 medications that may interact with Myalept
- View Myalept alcohol/food interactions (1)
- View Myalept disease interactions (4)
Most frequently checked interactions
View interaction reports for Myalept (metreleptin) and the medicines listed below.
- Actemra (tocilizumab)
- Actimmune (interferon gamma-1b)
- Adasuve (loxapine)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Adzynma (apadamtase alfa, recombinant)
- Afrezza (insulin inhalation, rapid acting)
- Aimovig (erenumab)
- alosetron
- ambrisentan
- Amondys 45 (casimersen)
- Blincyto (blinatumomab)
- Caprelsa (vandetanib)
- Eliquis (apixaban)
- Entyvio (vedolizumab)
- Letairis (ambrisentan)
- Lumizyme (alglucosidase alfa)
- Opsumit (macitentan)
- Pomalyst (pomalidomide)
- Prolia (denosumab)
- Revlimid (lenalidomide)
- Sabril (vigabatrin)
- Soliris (eculizumab)
- Stelara (ustekinumab)
- Tracleer (bosentan)
- Trulicity (dulaglutide)
- Tysabri (natalizumab)
- Xeljanz (tofacitinib)
- Yervoy (ipilimumab)
Myalept alcohol/food interactions
There is 1 alcohol/food interaction with Myalept (metreleptin).
Myalept disease interactions
There are 4 disease interactions with Myalept (metreleptin) which include:
More about Myalept (metreleptin)
- Myalept consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.